ArticlePerioperative medicine (London, England)2025
Perineural versus intravenous dexamethasone for single-shot interscalene block in arthroscopic shoulder surgery: a systematic review and meta-analysis of studies published through May 2021.
Article in Perioperative medicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAlthough both perineural and intravenous dexamethasone have been shown to extend the analgesic duration of single-shot interscalene brachial plexus blocks (ISB), the optimal route of administration remains uncertain. This meta-analysis systematically compares the efficacy and safety of perineural versus intravenous dexamethasone as adjuvants to ISB in patients undergoing arthroscopic shoulder surgery.
methodsPrimary outcomes assessed were analgesia duration, sensory block duration, and motor block duration. Secondary outcomes included postoperative pain scores, opioid consumption, and the incidence of adverse events, such as local anesthetic systemic toxicity (LAST). We systematically searched PubMed, Embase, and Web of Science from inception to May 31, 2021 under a prespecified protocol; studies published thereafter were beyond the scope of this review.
resultsA total of seven studies involving 846 patients were included in this analysis. Compared with intravenous administration, perineural injection of dexamethasone significantly prolonged analgesia duration (weighted mean difference WMD: 1.699 h; 95% confidence interval CI: 0.014-3.384; p = 0.048) and reduced postoperative pain scores at 12 h (WMD: -0.652; 95% CI: -1.129 to -0.176; p = 0.007). No significant differences were observed in sensory or motor block durations, postoperative pain scores, and opioid consumption at 24 h, or the incidence of adverse events, including dyspnea, sleep disturbances, and postoperative glucose level fluctuations.
conclusionsCompared with the intravenous route, perineural dexamethasone modestly prolongs the duration of analgesia after single-shot interscalene block (approximately 2 h). However, the associated reductions in postoperative pain scores are small and unlikely to reach commonly cited MCID thresholds, rendering the overall clinical importance uncertain. These findings support cautious interpretation and individualized route selection rather than generalized claims of superiority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.